Who will Blink First? 340B Health at Center Stage as Controversy Continues

Maureen Testoni, the stalwart president and CEO of the renowned 340B Health Program, will join the long-running Monitor Mondays to discuss Eli Lilly’s escalating demands for hospitals to submit in-house claims data as a condition of receiving 340B drug discounts. Who will blink first? Register now to reserve your participation. Broadcast segments will also include these instantly recognizable features: · Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds. · The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors. · Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment. · Legislative Update: Folana Houston, legislative affairs analyst for Zelis, will report on current healthcare legislation.